Lyxor has launched the Lyxor Scientific Beta Developed Long/Short UCITS ETF – EUR-Acc on Xetra and Börse Frankfurt.
The equity index ETF is designed to enable investors to participate in the performance of large and mid-cap companies from industrialised countries. The benchmark index aims to offer absolute performance with low volatility and a low correlation with the broad spectrum of the equity market. The companies in the benchmark index are selected on the basis of six factors: size, value, momentum, low volatility, profitability and investment. The benchmark index al-so contains a short position on a broad capitalisation-weighted index in order to minimise the total beta of the equity market. The strategy includes leverage, which amplifies the upward and downward movements.
Ongoing charges on the fund are 0.55 per cent and the distribution policy is accumulating.